J1631 Medicaid reimbursement rate by state (2026)
Injection, haloperidol decanoate, per 50 mg. Medicaid pays a median of $5.29 for J1631 across 39 states, from $2.30 in North Carolina to $29.55 in Arkansas.
- States publishing
- 39
- National median
- $5.29units vary by state
- Lowest
- $2.30North Carolina
- Highest
- $29.55Arkansas
What does Medicaid pay for J1631?
39 state Medicaid programs publish a fee-for-service rate for J1631. The national median is $5.29 (units differ between states). Arkansas pays the most, $29.55, and North Carolina the least, $2.30, a 12.8x spread.
J1631 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 39 states with every variant, modifier and effective date.
How to read this table
- Order. States are listed from the highest published rate to the lowest. No single unit is shared by 8 or more states for J1631, so the order is by published amount and is not a like-for-like rank.
- Medicaid rate. The most the state's fee-for-service program pays for one unit, as published. 17 of the 39 states list more than one rate for J1631, by modifier, provider type or setting; the table shows the one that matches the provider level and setting used across states, without add-ons.
- Unit. Of the 39 states, 1 publish J1631 per 50 mg and 1 per unit, and 37 schedules print no unit at all (a flat amount per service).
- Per hour. J1631 is not billed in time units in these states, so no hourly figure is shown.
- Managed-care plans. The rule the state sets for its plans on this rate. What each rule means is explained below.
- % of Medicare. No Medicare physician fee schedule amount is on file for J1631, so there is no percentage.
- Source and date. Each Source link opens the state's own document; “since” is the date the rate took effect.
Why J1631 rates differ between states
Published rates for J1631 run from $2.30 in North Carolina to $29.55 in Arkansas, a 12.8x gap in the same unit. Half the states pay more than the median of $5.29 and half pay less. The usual reasons for a spread like this in pharmacy rates:
- Drugs given in a practice or clinic are commonly priced from a benchmark such as average sales price or wholesale acquisition cost, which moves every quarter.
- For children, many vaccines are supplied through the federal Vaccines for Children program, so the Medicaid payment can be for administration only.
- States differ in whether they pay a fixed fee, a percentage of a benchmark or invoice cost.
Timing matters too. 32 states set the current rate for J1631 in 2026 or later, while 1 state still pay a rate that took effect in 2022 or earlier. A state that has not updated its rate in years will drift down the ranking as others raise theirs.
What managed-care plans pay for J1631
Most Medicaid members are in managed-care plans, and plans don't publish their provider fee schedules. For J1631, the public signal is the rule each state sets for its plans, recorded on each rate above.
In 8 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 16 states, plans negotiate and the published rate is a benchmark or out-of-network default. In 1 state, the service is paid outside the plans or through a state-directed payment. The rule for the remaining 14 states is not classified yet.
- Plans negotiate; the published rate applies out of network (16 states). In-network rates can be above or below the published rate. The published rate is the benchmark both sides know, and the fallback if no contract is signed.
- Plans must pay at least the published rate (7 states). The published rate is your floor. Negotiate up from it, and if a plan pays less, the contract provision is the basis for a payment dispute.
- Paid by the state, outside the plans (1 state). Bill the state's Medicaid program, not the plan, at the published rate. There is no plan contract to negotiate for this service.
- The state sets the plan rate (1 state). There is little to negotiate on price. Contracting is about network participation, authorization and billing terms.
Plan-negotiated rates are never estimated here. To see the rule and its citation for a particular state, open that state's managed-care page, for example Arkansas managed care.
Units and billing for J1631
J1631 is a HCPCS Level II drug code in the pharmacy line, billed mostly by practices and clinics that administer vaccines and drugs. J codes cover drugs that are not self-administered. One unit is the dose stated in the code, so a claim for a larger dose bills several units.
Many states require the National Drug Code (NDC) on the claim alongside the billing code. Drug codes are billed in units of the dose stated in the code, so a larger dose bills more units.
Before billing, confirm the rate, unit and any modifier with the state's current schedule or the plan: the amounts here are as published, not a guarantee of payment.
Frequently asked questions
What does Medicaid pay for J1631?
It depends on the state. Of the 39 states with a published fee-for-service rate, the median is $5.29. Arkansas pays the most ($29.55) and North Carolina the least ($2.30).
Which state pays the highest Medicaid rate for J1631?
Arkansas, at $29.55, effective 2025-06-13.
Which state pays the lowest Medicaid rate for J1631?
North Carolina, at $2.30, effective 2022-01-01.
What unit is J1631 billed in?
Of the 39 states, 1 publish J1631 per 50 mg and 1 per unit, and 37 schedules print no unit at all (a flat amount per service).
Do managed-care plans pay the same rate for J1631?
Not necessarily. In 8 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 16 states, plans negotiate and the published rate is a benchmark or out-of-network default. In 1 state, the service is paid outside the plans or through a state-directed payment. The rule for the remaining 14 states is not classified yet. Each rule is cited to the plan contract, statute or notice in the workspace.